N※N

CDC Appoints Dr. Claire Hannan as Acting Director

  //health-fitness.news-articles.net/content/2026/ .. ppoints-dr-claire-hannan-as-acting-director.html
  Published in Health and Fitness on Wednesday, February 18th 2026 at 16:21 GMT by WSB-TV
      Locale: UNITED STATES

ATLANTA, GA - February 18, 2026 - The Centers for Disease Control and Prevention (CDC) has entered a new chapter with the appointment of Dr. Claire Hannan as its acting director. The move follows the recent resignation of Dr. Rochelle Walensky and arrives at a pivotal moment for public health, as the nation continues to grapple with lingering impacts from recent pandemics and the evolving challenges of emerging infectious diseases.

Dr. Hannan, currently the Chief Executive Officer of the Association of State and Territorial Health Officials (ASTHO), brings a wealth of experience deeply rooted in the collaborative landscape of public health. ASTHO represents the state and territorial health agencies, giving Dr. Hannan unparalleled insight into the capabilities, needs, and challenges faced by public health departments across the country. This background is widely seen as a deliberate and potentially transformative choice by the Biden administration, signaling a clear intention to strengthen the CDC's partnerships with those on the front lines of public health.

Dr. Walensky's tenure, while marked by the immense pressure of navigating the COVID-19 pandemic, was also subject to considerable scrutiny regarding the CDC's communication strategies and perceived slowness in adapting to rapidly changing circumstances. Critics frequently pointed to a top-down approach that often bypassed or undervalued the expertise and lived experiences of local health officials. The appointment of Dr. Hannan appears to be a direct response to these criticisms.

"The CDC has historically operated with a significant degree of centralized control," explains Dr. Emily Carter, a public health policy analyst at the University of Georgia. "While this isn't inherently negative, it often led to disconnects between federal guidance and the realities on the ground. Dr. Hannan's experience at ASTHO uniquely positions her to bridge that gap."

The transition will be phased, with Quentin Harp serving as interim director until Dr. Hannan officially assumes the role. This provides a crucial period for continuity while allowing Dr. Hannan to familiarize herself with the inner workings of the CDC and begin formulating her priorities. The search for a permanent director remains underway, and it is anticipated that Dr. Hannan may be a strong contender for the permanent position.

Focus on Public Health Preparedness & Response

Beyond strengthening state and local partnerships, Dr. Hannan is expected to prioritize bolstering public health preparedness and response capabilities. The lessons learned from the COVID-19 pandemic highlighted critical vulnerabilities in the nation's public health infrastructure, including insufficient funding, workforce shortages, and data interoperability issues.

During her time at ASTHO, Dr. Hannan has been a vocal advocate for increased investment in public health infrastructure and a modernized approach to data collection and analysis. She has championed the use of innovative technologies and data-driven strategies to improve disease surveillance, outbreak detection, and response efforts.

"One of the biggest challenges we face is the fragmented nature of public health data," Dr. Hannan stated in a recent ASTHO webinar. "We need to move towards a more integrated and interoperable system that allows us to rapidly share information across jurisdictions and identify emerging threats before they escalate."

Addressing Long-Term Health Threats

While infectious disease control remains a core focus, the CDC under Dr. Hannan's leadership is also likely to address a broader range of long-term health threats, including chronic diseases, climate change, and health disparities. These issues require a multi-faceted approach that involves collaboration across sectors and a commitment to addressing the social determinants of health.

The CDC's ability to effectively address these challenges will depend on its ability to foster strong relationships with community-based organizations, healthcare providers, and other stakeholders. Dr. Hannan's experience in building consensus and fostering collaboration will be invaluable in this regard.

Experts suggest that Dr. Hannan's appointment signals a shift in the CDC's operating philosophy - one that prioritizes collaboration, responsiveness, and a deeper understanding of the needs of communities across the nation. The coming months will be crucial in determining how this new approach unfolds and its impact on the future of public health in the United States.